While from Indian side, it is coordinated by Department of Science and Technology (DST) with members from Council for Scientific and Industrial Research (CSIR), Indian Council for Medical Research (ICMR), Department of Biotechnology (DBT) and other scientific departments of India, the Japanese side is represented by its ministry of foreign affairs with members from education, science, health, industry and other relevant ministries.

With a view to represent the demands of the Indian pharma companies in Japan, the Pharmaceutical Export Promotion Council of India (Pharmexcil), set up by ministry of commerce and and industry, constituted an indigenous body called India-Japan Pharma Alliance in Japan last year. This body will be acting as the Pharmexcil's frontal agency to represent the issues and the challenges faced by the Indian pharmaceutical companies in Japan.

The Confederation of Indian Industries (CII) report 2012 titled "India-Japan: A Growing Strategic Relationship" has predicted that the two countries would achieve a trade target of $25 billion by 2014.
Strong mutual complementarities between two nations are driving the trade and potential sectors of trade and investment including capital goods, auto parts, chemicals and pharmaceuticals among a wide range. It is very important for both the nations to encourage bioscience cooperation and lay down a concrete road map for the future.